Thermo Fisher Scientific plans to acquire a Philadelphia-based clinical trial software company for $8.9 billion.

The deal brings together firms that hope to redefine how payment providers manage risk.

The new funding comes just six months after a Series D round pulled in $356 million for the Kirkland, Wash.-based company.

Travel software company Navan’s initial public offering struggled Thursday with shares falling by more than 15%. The offering was priced at $25 a share and the company raised $923 million. The startup ...

OpenAI said today it has bought a company called Software Applications Inc., which is building an artificial ...

Legal AI startup Harvey’s valuation has jumped by billions this year, a supercharged growth rate rare even in a climate of ...

Alphabet’s venture firm GV is leading the round, which nearly doubles Synthesia’s valuation, per three sources.

Figma Just Spent $200 Million on an AI Start-Up. Here's Why It Could Be What Investors Have Been Waiting For. Figma is moving ...

OpenAI’s acquisition of the company — renowned for developing Sky — advances its mission to integrate AI into people’s daily ...

OpenAI may get most of the attention, but these two-dozen companies finding their way in AI by making vibe-coding software, ...

OpenAI on Thursday said it bought Software Applications Inc. for an undisclosed sum. The two-year-old artificial intelligence startup develops Sky, which allows Mac users to take action on their ...

A new survey of early-stage Seattle founders reveals that AI isn’t just helping write code — in some cases, it’s doing most ...